However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Ozempic, Mounjaro, Wegovy, Victoza and Trulicity are part of a class of diabetes and obesity medications called GLP-1 drugs.

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...